BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

JHP Pharmaceuticals to Produce Clinical and Commercial Supply of an Innovative Injectable


6/5/2012 11:58:35 AM

PARSIPPANY, N.J., June 5, 2012 /PRNewswire/ -- JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile products has entered into an agreement with an undisclosed pharmaceutical company to produce clinical and commercial supply of an innovative injectable used in the cardiovascular setting.

Stuart Hinchen, president and CEO of JHP stated, "We are pleased to serve this important customer and recognize that being selected to produce this injectable is based on our expertise with complex formulations coupled with our competence in both clinical supply and commercial supply."

Hinchen noted, "JHP's extensive experience working with products through their life cycle starting with clinical trials through approval, product launch and global commercialization provides customers with a measure of confidence allowing them to focus on their day-to-day business priorities."

JHP's Rochester, Michigan manufacturing site's 25-year history in contract manufacturing is a result of a solid cGMP compliance record, a quality-driven experienced staff and a customer-centric approach.

About JHP Pharmaceuticals, LLC

JHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile products including biologics, small molecule, controlled substances, vaccines, ophthalmics, otics and antibiotics for large and small pharmaceutical and biotech organizations.

JHP's sterile manufacturing facility, located in Rochester Michigan sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse. The production facility utilizes three high-speed filling lines, a clinical filling line and four lyophilizers. The site also includes separate facilities for chemistry, sterility testing, and analytical methods development.

JHP has the capability to manufacture small-scale clinical through large-scale commercial products. JHP employs more than 370 staff in the USA in its manufacturing, product development, regulatory, sales and marketing and corporate areas. For more information, please visit www.jhppharma.com.

Contact:

Dan Leone
973.658.3559

Bill Conway
877.906.7556
jhpcontractservices@jhppharma.com

MK343

SOURCE JHP Pharmaceuticals, LLC



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES